FI99211B - Menetelmä hirudiinivariantin valmistamiseksi - Google Patents

Menetelmä hirudiinivariantin valmistamiseksi

Info

Publication number
FI99211B
FI99211B FI875295A FI875295A FI99211B FI 99211 B FI99211 B FI 99211B FI 875295 A FI875295 A FI 875295A FI 875295 A FI875295 A FI 875295A FI 99211 B FI99211 B FI 99211B
Authority
FI
Finland
Prior art keywords
preparing
hirudin variant
hirudin
variant
amino acid
Prior art date
Application number
FI875295A
Other languages
English (en)
Swedish (sv)
Other versions
FI99211C (fi
FI875295L (fi
FI875295A0 (fi
Inventor
Michael Courtney
Eric Degryse
G Rard Loison
Yves Lemoine
Original Assignee
Transgene Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transgene Sa filed Critical Transgene Sa
Publication of FI875295A0 publication Critical patent/FI875295A0/fi
Publication of FI875295L publication Critical patent/FI875295L/fi
Publication of FI99211B publication Critical patent/FI99211B/fi
Application granted granted Critical
Publication of FI99211C publication Critical patent/FI99211C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81Protease inhibitors
    • C07K14/815Protease inhibitors from leeches, e.g. hirudin, eglin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Cosmetics (AREA)
FI875295A 1986-12-01 1987-12-01 Menetelmä hirudiinivariantin valmistamiseksi FI99211C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8616723 1986-12-01
FR868616723A FR2607517B2 (fr) 1986-12-01 1986-12-01 Vecteurs d'expression de variants de l'hirudine dans les levures, procede et produit obtenu

Publications (4)

Publication Number Publication Date
FI875295A0 FI875295A0 (fi) 1987-12-01
FI875295L FI875295L (fi) 1988-06-02
FI99211B true FI99211B (fi) 1997-07-15
FI99211C FI99211C (fi) 1997-10-27

Family

ID=9341393

Family Applications (1)

Application Number Title Priority Date Filing Date
FI875295A FI99211C (fi) 1986-12-01 1987-12-01 Menetelmä hirudiinivariantin valmistamiseksi

Country Status (24)

Country Link
US (1) US5650301A (fi)
EP (1) EP0273800B1 (fi)
JP (1) JP2567263B2 (fi)
KR (1) KR960011918B1 (fi)
AT (1) ATE73462T1 (fi)
AU (1) AU617989B2 (fi)
BG (1) BG49719A3 (fi)
CA (1) CA1341416C (fi)
CS (1) CS276245B6 (fi)
DE (1) DE3777367D1 (fi)
DK (1) DK173247B1 (fi)
ES (1) ES2032465T3 (fi)
FI (1) FI99211C (fi)
FR (1) FR2607517B2 (fi)
GR (1) GR3004556T3 (fi)
HU (1) HU213871B (fi)
IE (1) IE60544B1 (fi)
MC (1) MC1884A1 (fi)
NO (1) NO177500C (fi)
PL (1) PL157254B1 (fi)
PT (1) PT86233B (fi)
RO (1) RO106890B1 (fi)
SU (1) SU1687032A3 (fi)
ZA (1) ZA879011B (fi)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2628429B1 (fr) * 1988-03-08 1990-12-28 Transgene Sa Variants de l'hirudine, leurs utilisations et les procedes pour les obtenir
GB8817161D0 (en) * 1988-07-19 1988-08-24 Ciba Geigy Ag Modified proteins
GB8817160D0 (en) * 1988-07-19 1988-08-24 Ciba Geigy Ag Novel proteins
US5284768A (en) * 1988-08-24 1994-02-08 Sanofi Signal peptide, DNA sequences coding for the latter, expression vectors carrying one of these sequences, gram-negative bacteria transformed by these vectors, and process for the periplasmic production of a polypeptide
US5879926A (en) * 1989-03-31 1999-03-09 Transgene S.A. Yeast strains for the production of mature heterologous proteins, especially hirudin
FR2645175B1 (fr) * 1989-03-31 1994-02-18 Transgene Sa Souche de saccharomyces cerevisiaeproductrice d'une proteine heterologue et procede de preparation de ladite proteine heterologue par fermentation de ladite souche
FR2645174B1 (fr) * 1989-03-31 1994-01-07 Transgene Sa Souches de levure ameliorees pour la production de proteines heterologues matures en particulier d'hirudine et procede de preparation d'hirudine correspondant
FR2646437B1 (fr) * 1989-04-28 1991-08-30 Transgene Sa Nouvelles sequences d'adn, leur application en tant que sequence codant pour un peptide signal pour la secretion de proteines matures par des levures recombinantes, cassettes d'expression, levures transformees et procede de preparation de proteines correspondant
FR2656531B1 (fr) * 1989-12-29 1992-04-24 Sanofi Sa Promoteur artificiel pour l'expression de proteines dans le levure.
US5118790A (en) * 1990-07-24 1992-06-02 Sri International Analogs of hirudin
ATE176500T1 (de) * 1990-11-08 1999-02-15 Japan Energy Corp Sekretionsvektor, diesen enthaltene transformierte mikroorganismen und herstellung von produkten durch obigen mikroorganismus
US5837808A (en) * 1991-08-20 1998-11-17 Baxter International Inc. Analogs of hirudin
US5407822A (en) * 1991-10-02 1995-04-18 Sanofi Artificial promoter for the expression of proteins in yeast
US12466852B2 (en) 2019-04-16 2025-11-11 Sungen Bioscience Co., Ltd. Method for extraction and purification of hirudin mutant and use thereof
WO2025262265A1 (en) 2024-06-21 2025-12-26 Etablissement Francais Du Sang Chimeric molecules comprising an anti-fibrin antibody and an antithrombotic molecule

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3586333T2 (de) * 1984-03-27 1992-12-10 Transgene Sa Expressionsvektoren fuer hirudin, transformierte zellen und verfahren zur herstellung von hirudin.
DE3583361D1 (de) * 1984-06-14 1991-08-08 Ucp Gen Pharma Ag Verfahren zur herstellung von thrombin-inhibitoren.
DE3429430A1 (de) * 1984-08-10 1986-02-20 Hoechst Ag, 6230 Frankfurt Gentechnologisches verfahren zur herstellung von hirudin und mittel zur durchfuehrung dieses verfahrens
DE3445517C2 (de) * 1984-12-13 1993-11-18 Ciba Geigy Für ein Hirudin-ähnliches Protein codierende DNA-Sequenz und Verfahren zur Herstellung eines Hirudin-ähnlichen Proteins
FR2593518B1 (fr) * 1985-05-02 1989-09-08 Transgene Sa Vecteurs d'expression et de secretion de l'hirudine par les levures transformees
EP0209061B1 (de) * 1985-07-17 1994-01-12 Hoechst Aktiengesellschaft Neue Polypeptide mit blutgerinnungshemmender Wirkung, Verfahren zu deren Herstellung bzw. Gewinnung, deren Verwendung und diese enthaltende Mittel

Also Published As

Publication number Publication date
DE3777367D1 (de) 1992-04-16
HUT45564A (en) 1988-07-28
SU1687032A3 (ru) 1991-10-23
EP0273800B1 (fr) 1992-03-11
ZA879011B (en) 1988-05-27
CS276245B6 (en) 1992-05-13
CS8708732A2 (en) 1991-07-16
DK627687D0 (da) 1987-11-30
RO106890B1 (ro) 1993-07-30
DK627687A (da) 1988-06-02
PT86233B (pt) 1990-11-07
PL157254B1 (pl) 1992-05-29
NO177500B (no) 1995-06-19
KR960011918B1 (ko) 1996-09-04
NO177500C (no) 1995-09-27
NO874905D0 (no) 1987-11-25
EP0273800A2 (fr) 1988-07-06
BG49719A3 (bg) 1992-01-15
MC1884A1 (fr) 1989-01-24
US5650301A (en) 1997-07-22
ES2032465T3 (es) 1993-02-16
ATE73462T1 (de) 1992-03-15
FI99211C (fi) 1997-10-27
JPS63152987A (ja) 1988-06-25
CA1341416C (fr) 2003-01-21
DK173247B1 (da) 2000-05-22
FR2607517A2 (fr) 1988-06-03
AU617989B2 (en) 1991-12-12
JP2567263B2 (ja) 1996-12-25
PT86233A (fr) 1987-12-01
GR3004556T3 (fi) 1993-04-28
IE873239L (en) 1988-06-01
NO874905L (no) 1988-06-02
FI875295L (fi) 1988-06-02
FI875295A0 (fi) 1987-12-01
EP0273800A3 (en) 1988-07-20
HU213871B (en) 1997-11-28
FR2607517B2 (fr) 1989-12-22
IE60544B1 (en) 1994-07-27
PL269164A1 (en) 1988-08-18
AU8188087A (en) 1988-06-02
KR880007729A (ko) 1988-08-29

Similar Documents

Publication Publication Date Title
DK340088A (da) Aminosyrederivater
ATE142258T1 (de) Menschlicher gefässpermeabilitätsfaktor
FI99211B (fi) Menetelmä hirudiinivariantin valmistamiseksi
DK565987A (da) Substituerede aminosyrer
DE68925240D1 (de) Phosphinsäure-Derivate
ATE140962T1 (de) Dns-klone von menschlichem thrombomodulin
ATE71658T1 (de) Verfahren zur herstellung von humanlysozym.
DK523288D0 (da) Aminosyrederivater
NO883960L (no) Arylcyklobutenylamidoalkensyrer og salter derav.
DK207388D0 (da) Nitrogenholdige, cycloaliphatiske forbindelser med en aminosyregruppe samt en pyridingruppe
KR870700630A (ko) 지방족 포스폰산류의 제조방법
EP0127467A3 (en) Self incompatibility glycoprotein
DE68908843D1 (de) Verfahren zur Herstellung von 4,6-Dimethyl-7-hydroxynonan-3-on.
IT8619594A1 (it) Acid 8-osso-2-ossa-l-azabiciclo 4.2.0 ottano-3-carbossilici
DE3877197D1 (de) Verfahren zur herstellung von hirudin.
DE68914950D1 (de) Aminsalze von 1,4,2-Oxazaphospholidin-2-alkoxy-2-oxid-4-essigsäuren.
BG43689A3 (en) Method for preparing of n- substituted derivatives of aminopropane sulphonic acid
FI884177A7 (fi) Menetelmä L-aminohappojen valmistamiseksi.
ATE95518T1 (de) Aminosaeure-derivate.

Legal Events

Date Code Title Description
FG Patent granted

Owner name: TRANSGENE S.A.

BB Publication of examined application
FG Patent granted

Owner name: SCHERING AKTIENGESELLSCHAFT

MA Patent expired